In the era of coronavirus disease 2019 (COVID-19), the management of cardiac implantable electronic devices infections with concomitant viral infection has not been completely defined yet. In this explorable context, we report the first experience of a Cardiac resynchronization therapy with defibrillator (CRT-D) implantation after transvenous lead extraction for endocarditis in a COVID-19 patient. We describe both the measures and procedures implemented to reduce the cross-infection in the operating room and our clinical practice to improving procedure effectiveness on patient care.

CONFLICTS OF INTEREST

None declared.

REFERENCES

1Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm. 2009; 6(7): 1085-104.
10.1016/j.hrthm.2009.05.020
PubMed Web of Science® Google Scholar
2Sood N, Martin DT, Lampert R, Curtis JP, Parzynski C, Clancy J. Incidence and predictors of perioperative complications with transvenous lead extractions real-world experience with National Cardiovascular Data Registry. Circ Arrhythm Electrophysiol. 2018; 11(2):e004768.
10.1161/CIRCEP.116.004768
PubMed Web of Science® Google Scholar
3Daniele A, Elena A, Emanuele B, et al. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology. European Heart Journal, 2022
Google Scholar
4Lakkireddy DR, Chung MK, Gopinathannair R, et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 task force; electrophysiology section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. 2020; 17(9): e233-e241.
PubMed Web of Science® Google Scholar
5Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. HRS Expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm Soc. 2017; 14(12): e503-e551.
10.1016/j.hrthm.2017.09.001
PubMed Web of Science® Google Scholar
6Blomström-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020; 22(4): 515-549.
10.1093/europace/euz246
PubMed Web of Science® Google Scholar
7Liang T Handbook of COVID-19 Prevention and Treatment. 2020
Google Scholar
8Anesthetic management of patients with COVID 19 infections during emergency procedures. J Cardiothorac Vasc Anesth. 2020; 34(5): 1125-1131.
10.1053/j.jvca.2020.02.039
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume45, Issue6

June 2022

Pages 807-810

CRT implantation after transvenous lead/device extraction (TLE) in a patient with COVID-19: Endocarditis triggered by syndrome coronavirus 2 (SARS-COV-2) infection? A case report

Abstract

CONFLICTS OF INTEREST

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

CRT implantation after transvenous lead/device extraction (TLE) in a patient with COVID-19: Endocarditis triggered by syndrome coronavirus 2 (SARS-COV-2) infection? A case report

Abstract

CONFLICTS OF INTEREST

REFERENCES

Citing Literature

References

Related

Information